Sort
15,842 grants matching “pancreatic cancer”
Eosinophil Recruitment and Activation in Solid Tumors
$294,008James Joseph Lee · Mayo Clinic Arizona · R01 · FY2007 · CA
The Antigen Targeting Core
$293,989Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO
$293,948Rachael Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
$293,941Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2022 · CA
Project 3 - HDAC/GSK-3B/YAP signaling network in the liver metastatic microenvironment
$293,894Stephen J Pandol · Cedars-Sinai Medical Center · P01 · FY2024 · CA
PANCREATIC CANCER RISK PREDICTED FROM ELECTRONIC HEALTH RECORDS IN U.S. VETERANS USING ARTIFICIAL INTELLIGENCE
$293,843Boston Va Research Institute, Inc. · · FY2025 · Defense Health Agency
Gli Activity in the Pancreas: Inflammation, Tissue Repair and Cancer
$293,837Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
T Cell Immunity to Epithelial Tumor Mucins
$293,802University Of Pittsburgh At Pittsburgh · R01 · FY2004 · CA
Exploiting new approaches for selective inhibition of trypsins
$293,784Evette S Radisky · Mayo Clinic Jacksonville · R01 · FY2023 · GM
Harnessing p27 for Prognostication of Pediatric Osteosarcoma
$293,758Tsz-Kwong Man · Baylor College Of Medicine · R01 · FY2013 · HD
BRCA1/2 and Hereditary Breast, Ovarian and Pancreatic (HBOP) Cancer Variant Curation Expert Panels
$293,689Fergus Joseph Couch · Mayo Clinic Rochester · U24 · FY2022 · CA
Gene Amplification and Deletion in Pancreatic Cancer
$293,668Jonathan R Pollack · Stanford University · R01 · FY2006 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$293,564Andrew M Lowy · University Of California, San Diego · R01 · FY2011 · CA
Mechanisms & Therapeutic Targeting of the Microenvironment in Pancreatic Cancer
$293,541Douglas Hanahan · Dana-Farber Cancer Inst · P01 · FY2008 · CA
The Hippo Signaling Pathway in Pancreatic Cancer
$293,520Anirban Maitra · Johns Hopkins University · P01 · FY2012 · CA
Aurora Kinases as Therapeutic Targets in Pancreatic Cancer
$293,406Daniel D Von Hoff · Translational Genomics Research Inst · R01 · FY2008 · CA
Combination therapy using tumor-targeting synthetic dsRNA and gemcitabine
$293,395Zhengrong Cui · Oregon State University · R01 · FY2008 · CA
Combination therapy using tumor-targeting synthetic dsRNA and gemcitabine
$293,365Zhengrong Cui · University Of Texas At Austin · R01 · FY2011 · CA
Profiling Circulating miRNA Without PCR for Early Detection of Pancreatic Cancer
$293,322Ravi Saraf · Vajra Instruments, Inc. · R43 · FY2015 · CA
T Cell Immunity to Epithelial Tumor Mucins
$293,193University Of Pittsburgh At Pittsburgh · R01 · FY2005 · CA
Early Detection of Human Colorectal and Pancreatic Cancer
$293,167Kenneth W. Kinzler · Johns Hopkins University · P50 · FY2009 · CA
Exploiting new approaches for selective inhibition of trypsins
$293,116Evette S Radisky · Mayo Clinic Jacksonville · R01 · FY2025 · GM
Core 2: Human Specimen and Organic Core (HSO Core)
$293,113Herve Tiriac · Salk Institute For Biological Studies · P01 · FY2023 · CA
PH 1 XRT+5 FU+ENILURACIL--ADVANCED UNRESECTABLE UPPER GI MALIGNANCIES
$293,069Duke University · M01 · FY2001 · RR
PH I: SYNTHETIC SECRETIN TO EVALUATE EXOCRINE PANCREATIC FUNCTION
$293,069Duke University · M01 · FY2001 · RR